Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Bristol-Myers Squibb Co    BMY

Delayed Quote. Delayed  - 06/24 10:04:38 pm
70.61 USD   -2.79%
06/25 BRISTOL MYERS S : Sickle Cell Partnership Creates Demonstration Proj..
06/24 BRISTOL MYERS S : Sickle Cell Partnership Creates Demonstration Proj..
06/23 BRISTOL MYERS S : AROUND THE DISTRICT Museums' future looks exciting
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Bristol-Myers Gets SEC Subpoena In Foreign Bribery Probe

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/26/2012 | 07:01pm CEST
   By Peter Loftus 
   Of  
 

Drug maker Bristol-Myers Squibb Co. (>> Bristol Myers Squibb Co.) said it has received a subpoena from the U.S. Securities and Exchange Commission as part of an investigation into bribery overseas.

Bristol-Myers said the subpoena received in March seeks information related to sales and marketing practices in "various countries."

The New York-based company said in a quarterly report filed Thursday with the SEC that it was cooperating with the government. A spokeswoman declined comment beyond the information in Thursday's SEC filing.

Bristol-Myers, which sells the anti-clotting drug Plavix, previously disclosed that the SEC was investigating the activities of the company's units in Germany, concerning potential violations of the U.S. Foreign Corrupt Practices Act, or FCPA.

U.S. authorities in recent years have stepped up enforcement of the FCPA, which bars U.S. companies from bribing foreign officials to obtain or retain business. Multinational drug and medical-device makers based in the U.S. have been among the targets of enforcement.

Last year, Johnson & Johnson (>> Johnson & Johnson) agreed to pay nearly $80 million to resolve allegations that it paid bribes to doctors in three European countries, as well as kickbacks to Iraq to illegally obtain business under former leader Saddam Hussein.

Other drug makers--including Pfizer Inc. (>> Pfizer Inc.), Merck & Co. (>> Merck & Co., Inc.) and Eli Lilly & Co. (>> Eli Lilly & Co.)--also have been the subjects of federal inquiries regarding the FCPA.

-By Peter Loftus, Dow Jones Newswires; +1-215-982-5581; peter.loftus@dowjones.com

share with twitter share with LinkedIn share with facebook
share via e-mail
0
React to this article
Latest news on BRISTOL-MYERS SQUIBB CO
06/25 BRISTOL MYERS SQUIBB : Sickle Cell Partnership Creates Demonstration Project to ..
06/24 BRISTOL MYERS SQUIBB : Sickle Cell Partnership Creates Demonstration Project to ..
06/23 BRISTOL MYERS SQUIBB : AROUND THE DISTRICT Museums' future looks exciting
06/23 REPORTS FROM BRISTOL-MYERS SQUIBB AD : advances...
06/23 BRISTOL MYERS SQUIBB : Reports Outline Crohn's Disease Study Findings from Brist..
06/23 BRISTOL MYERS SQUIBB : Studies from Bristol-Myers Squibb Update Current Data on ..
06/23 BRISTOL MYERS SQUIBB : Reports on Rheumatoid Arthritis from Bristol-Myers Squibb..
06/23 BRISTOL MYERS SQUIBB : New Findings from Bristol-Myers Squibb in Type 1 Diabetes..
06/22 SolarCity and Bristol-Myers climb, Adobe and HP stumble
06/21 BRISTOL MYERS SQUIBB : Murdo Gordon Appointed Executive Vice President and Chief..
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials